Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q3 2024 Earnings Call Transcript
Operator: Good morning. My name is Alan, and I will be your conference operator today.
Amylyx Pharmaceuticals Inc. (AMLX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 6,774,348 | $25,607,035 | +219% | 0.7% |
| 2. | Almitas Capital Ron Mass | 2,032,370 | $7,682,359 | +3% | 1.68% |
| 3. | Citadel Investment Group Ken Griffin | 1,970,704 | $7,449,261 | +4% | 0% |
| 4. | 683 Capital Partners Ari Zweiman | 1,930,000 | $7,295,400 | -4% | 0.45% |
| 5. | Boxer Capital Aaron Davis And Christopher Fuglesang | 1,750,000 | $6,615,000 | 0.56% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.53 | 40,000 | 233,464 | 2024-09-12 | Filing | ||
| $2.13 | 50,000 | 55,000 | 2024-09-05 | Filing | ||
| $2.20 | 100,000 | 858,571 | 2024-09-03 | Filing | ||
| $1.89 | 2,250 | 5,000 | 2024-05-15 | Filing | ||
| $1.89 | 2,750 | 2,750 | 2024-05-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.49 | 3,678 | 139,090 | 2025-02-03 | Filing | ||
| $3.47 | 11,851 | 3,201,247 | 2025-02-03 | Filing | ||
| $3.47 | 11,855 | 3,164,933 | 2025-02-03 | Filing | ||
| $4.04 | 7,471 | 3,176,788 | 2025-01-06 | Filing | ||
| $4.05 | 7,471 | 3,213,098 | 2025-01-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,643,812 | $17,553,609 | 1.71% | |
| 2. | 2,692,489 | $10,177,608 | 0% | |
| 3. | 2,426,263 | $9,171,274 | 0% | |
| 4. | 2,278,934 | $8,614,370 | 0% | |
| 5. | 1,859,896 | $7,030,408 | 0% |
News See All
7 Best Nano Cap Stocks To Invest In
In one of our recent articles about 8 Most Undervalued Penny Stocks To Buy According To Analysts, we talked about how many analysts are expecting small caps to perform well in a slowing economy.
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q2 2024 Earnings Call Transcript
Operator: Good morning. My name is Camille, and I will be your conference operator for today.
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2024 Earnings Call Transcript
Amylyx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.75071 EPS, expectations were $0.24.
5 Best Value Penny Stocks To Invest In Now
“Furthermore, Five Point Holdings, LLC (NYSE:FPH) (a U.S.-based land development company) launched an exchange offer for its Senior Unsecured Notes, whereby it proposed to pay down $100 million of...
5 Oversold Biotech Stocks To Buy Right Now
In this article, we will be taking a look at 5 oversold biotech stocks to buy right now.
Analysts on Wall Street Lower Ratings for These 10 Stocks
In this article, we will discuss the 10 stocks recently downgraded by analysts.
5 Best Biotech Stocks To Buy Under $20
In this article, we are going to take a closer look at five best biotech stocks to buy under $20.
10 Biotech Stocks with Huge Potential
In this article, we will take a look at the 10 biotech stocks with huge potential.
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q4 2023 Earnings Call Transcript
Amylyx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.07 EPS, expectations were $0.2. Amylyx Pharmaceuticals, Inc.
Billionaire Hedge Funds
